Table S4 from Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

作者：Xiaoqing Cheng, Yirui Sun, Maureen Highkin, Nagalaxmi Vemalapally, Xiaohua Jin, Brandon Zhou, Julie L. Prior, Ashley R. Tipton, Shunqiang Li, Anton Iliuk, Samuel Achilefu, Ian S. Hagemann, John R. Edwards, Ron Bose · 年份：2025 · DOI：10.1158/0008-5472.30701374 · 研究领域：Advanced Breast Cancer Therapies、Cancer-related Molecular Pathways、PI3K/AKT/mTOR signaling in cancer

Phosphopeptides in Volcano Plot

Table S4 from Breast Cancer Mutations &lt;i&gt;HER2&lt;sup&gt;V777L&lt;/sup&gt;&lt;/i&gt; and &lt;i&gt;PIK3CA&lt;sup&gt;H1047R&lt;/sup&gt;&lt;/i&gt; Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance

Table S4 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance